Specific, functional effector/memory CD8+ T cells are found in the liver post-vaccination

Journal of Hepatology

Volumn 39, Issue 6, 2003, Pages 910-917

  Dikopoulos, Nektarios ^a   Jomantaite, Ieva ^a   Schirmbeck, Reinhold ^a   Reimann, Jörg ^a  

^a UNIVERSITY OF ULM   (Germany)

Author keywords

Hepatic CD8+ T cell immunity; Hepatic T cells; Hepatic tolerance

Indexed keywords

CD27 ANTIGEN; CD28 ANTIGEN; CD45 ANTIGEN; CD69 ANTIGEN; CD8 ANTIGEN; DNA VACCINE; EPITOPE; GAMMA INTERFERON; HERMES ANTIGEN; LIPOCORTIN 5;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CELL FUNCTION; CELL SPECIFICITY; CELLULAR IMMUNITY; CONGENIC STRAIN; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; EFFECTOR CELL; FEMALE; LIVER; MEMORY CELL; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; RODENT; T LYMPHOCYTE ACTIVATION; T LYMPHOCYTE SUBPOPULATION; VACCINATION;

EID: 0347906013     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8278(03)00469-0     Document Type: Article

References (38)

1. Mehal WZ, Azzaroli F, Crispe IN. Immunology of the healthy liver: old questions and new insights. Gastroenterology 2001;120:250-260.
2. Wick MJ, Leithäuser F, Reimann J. The hepatic immune system. Crit Rev Immunol 2002;22:47-103.
3. Crispe IN. Hepatic T cells and liver tolerance. Nat Rev Immunol 2003;3:51-62.
4. Huang L, Crispe IN. Superantigen-driven peripheral deletion of T cells. Apoptosis occurs in cells that have lost the αβ T cell receptor. J Immunol 1993;151:1844-1851.
5. Huang L, Soldevila G, Leeker M, Flavell R, Crispe IN. The liver eliminates T cells undergoing antigen-triggered apoptosis in vivo. Immunity 1994;1:741-749.
6. + T cell disposal. Eur J Immunol 1997;27:577-583.
7. + T cells triggered by high affinity peptide antigens. J Exp Med 1998;188:1147-1157.
8. Lee YC, Lu L, Fu F, Li W, Thomson AW, Fung JJ, et al. Hepatocytes and liver non-parenchymal cells induce apoptosis in activated T cells. Transplant Proc 1999;31:784.
9. + T cells by the normal liver. J Immunol 1999;163:3202-3210.
10. Luettig B, Pape L, Bode U, Bell EB, Sparshott SM, Wagner S, et al. Naive and memory T lymphocytes migrate in comparable numbers through normal rat liver: activated T cells accumulate in the periportal field. J Immunol 1999;163:4300-4307.
11. + T cells in the liver during the control and resolution phases of influenza pneumonia. Proc Natl Acad Sci USA 1998;95:13812-13817.
12. Liu ZX, Govindarajan S, Okamoto S, Dennert G. Fas- and tumor necrosis factor receptor 1-dependent but not perforin-dependent pathways cause injury in livers infected with an adenovirus construct in mice. Hepatology 2000;31:665-673.
13. Boehm W, Kuhröber A, Paier T, Mertens T, Reimann J, Schirmbeck R. DNA vector constructs that prime hepatitis B surface antigen-specific cytotoxic T lymphocyte and antibody responses in mice after intramuscular injection. J Immunol Methods 1996;193:29-40.
14. b mice. J Immunol 1996;156:3687-3695.
15. d mice that reject syngeneic tumors. J Immunol 1996;157:3550-3558.
16. Ballas ZK, Krieg AM, Warren T, Rasmussen W, Davis HL, Waldschmidt M, et al. Divergent therapeutic and immunologic effects of oligodeoxynucleotides with distinct CpG motifs. J Immunol 2001;167:4878-4886.
17. b-restricted epitope processed from exogenous but not endogenous hepatitis B surface antigen. Int Immunol 1999;11:1093-1102.
18. Janowicz ZA, Melber K, Merckelbach A, Jacobs E, Harford N, Comberbach M, et al. Simultaneous expression of the S and L surface antigens of hepatitis B, and formation of mixed particles in the methylotrophic yeast, Hansenula polymorpha. Yeast 1991;7:431-443.
19. Ishikawa T, Kono DH, Fowler P, Theofilopoulos AN, Kakumu S, Chisari FV. Polyclonality and multispecificity of the CTL response to a single viral epitope. J Immunol 1998;161:5842-5850.
20. Sette A, Oseroff C, Sidney J, Alexander J, Chesnut RW, Kakimi K, et al. Overcoming T cell tolerance to the hepatitis B virus surface antigen in hepatitis B virus-transgenic mice. J Immunol 2001;166:1389-1397.
21. Schirmbeck R, Wild J, Reimann J. Similar as well as distinct MHC-I-binding peptides are generated by exogenous and endogenous processing of hepatitis B virus surface antigen (HBsAg). Eur J Immunol 1998;28:4149-4161.
22. b-restricted epitopes in natural variants of the hepatitis B surface antigen. Eur J Immunol 2003;33:2429-2438.
23. Mylin LM, Schell TD, Roberts D, Epler M, Boesteanu A, Collins EJ, et al. Quantitation of CD8(+) T-lymphocyte responses to multiple epitopes from simian virus 40 (SV40) large T antigen in C57BL/6 mice immunized with SV40, SV40 T-antigen-transformed cells, or vaccinia virus recombinants expressing full-length T antigen or epitope minigenes. J Virol 2000;74:6922-6934.
24. + cytotoxic T lymphocyte responses in vivo. J Immunol 1994;152:1110-1119.
25. Trobonjaca Z, Leithäuser F, Moller P, Schirmbeck R, Reimann J. Activating immunity in the liver. I. Liver dendritic cells (but not hepatocytes) are potent activators of IFNγ release by liver NKT cells. J Immunol 2001;167:1413-1422.
26. Trobonjaca Z, Kroger A, Stober D, Leithäuser F, Moller P, Hauser H, et al. Activating immunity in the liver, II. IFN-β attenuates NK cell-dependent liver injury triggered by liver NKT cell activation. J Immunol 2002;168:3763-3770.
27. Stober D, Trobonjaca Z, Reimann J, Schirmbeck R. Dendritic cells pulsed with exogenous hepatitis B surface antigen particles efficiently present epitopes to MHC class I-restricted cytotoxic T cells. Eur J Immunol 2002;32:1099-1108.
28. Schirmbeck R, Boehm W, Ando K-I, Chisari FV, Reimann J. Nucleic acid vaccination primes hepatitis B surface antigen-specific cytotoxic T lymphocytes in non-responder mice. J Virol 1995;69:5929-5934.
29. Crispe IN, Dao T, Klugewitz K, Mehal WZ, Metz DP. The liver as a site of T-cell apoptosis: graveyard, or killing field? Immunol Rev 2000;174:47-62.
30. Singer GG, Abbas AK. The fas antigen is involved in peripheral but not thymic deletion of T lymphocytes in T cell receptor transgenic mice. Immunity 1994;1:365-371.
31. Sytwu HK, Liblau RS, McDevitt HO. The roles of Fas/APO-1 (CD95) and TNF in antigen-induced programmed cell death in T cell receptor transgenic mice. Immunity 1996;5:17-30.
32. + 4-8-double-negative lymphocytes in autoimmune MRL-lpr/lpr mice. J Exp Med 1990;172:7-12.
33. Tiegs G, Hentschel J, Wendel A. A T cell-dependent experimental liver injury in mice inducible by concanavalin A. J Clin Invest 1992;90:196-203.
34. Chen D, McKallip RJ, Zeytun A, Do Y, Lombard C, Robertson JL, et al. CD44-deficient mice exhibit enhanced hepatitis after concanavalin a injection: evidence for involvement of CD44 in activation-induced cell death. J Immunol 2001;166:5889-5897.
35. Liu ZX, Govindarajan S, Okamoto S, Dennert G. NK cells cause liver injury and facilitate the induction of T cell-mediated immunity to a viral liver infection. J Immunol 2000;164:6480-6486.
36. Huang L, Sye K, Crispe IN. Proliferation and apoptosis of B220 + CD4-CD8-TCR αβ intermediate T cells in the liver of normal adult mice: implication for lpr pathogenesis. Int Immunol 1994;6:533-540.
37. Guidotti LG, Chisari FV. To kill or to cure: options in host defense against viral infection. Curr Opin Immunol 1996;8:478-483.
38. Guidotti LG, Chisari FV. Non-cytolytic control of viral infections by the innate and adaptive immune response. Annu Rev Immunol 2001;19:65-91.